BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19562748)

  • 1. FLT3 mutations have no prognostic impact in elderly patients with acute myeloid leukemia and normal karyotype.
    Ferrara F; Criscuolo C; Riccardi C; Izzo T; Pedata M; Copia C; Vicari L; Tarsitano M; Palmieri S; Pane F
    Am J Hematol; 2009 Aug; 84(8):532-5. PubMed ID: 19562748
    [No Abstract]   [Full Text] [Related]  

  • 2. Importance of early detection and follow-up of FLT3 mutations in patients with acute myeloid leukemia.
    Colovic N; Tosic N; Aveic S; Djuric M; Milic N; Bumbasirevic V; Colovic M; Pavlovic S
    Ann Hematol; 2007 Oct; 86(10):741-7. PubMed ID: 17579862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of nucleophosmin mutations and Flt3 internal tandem duplications in patients older than 60 yr with acute myeloid leukaemia.
    Scholl S; Theuer C; Scheble V; Kunert C; Heller A; Mügge LO; Fricke HJ; Höffken K; Wedding U
    Eur J Haematol; 2008 Mar; 80(3):208-15. PubMed ID: 18081718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of FLT3 mutations does not impair stem cell mobilization and feasibility of autologous peripheral blood stem cell transplantation in acute myeloid leukemia.
    Ferrara F; Palmieri S; Pollio F; Lo Pardo C; Graziano D; Celentano M; D'Amico MR; Vicari L; Izzo B; Pane F
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):981-6. PubMed ID: 16920565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of CXCR4 predicts adverse overall and event-free survival in patients with unmutated FLT3 acute myeloid leukemia with normal karyotype.
    Konoplev S; Rassidakis GZ; Estey E; Kantarjian H; Liakou CI; Huang X; Xiao L; Andreeff M; Konopleva M; Medeiros LJ
    Cancer; 2007 Mar; 109(6):1152-6. PubMed ID: 17315232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloablative chemotherapy followed by autologous stem cell infusion may overcome the adverse prognostic impact of FLT3 (foetal liver tyrosine kinase 3) mutations in patients with acute myeloid leukaemia and normal karyotype.
    Palmieri S; Ferrara F; Leoni F; Ciolli S; Pollio F; D'Amico MR; Celentano M; Viola A; Vicari L; Izzo B; Pane F
    Hematol Oncol; 2007 Mar; 25(1):1-5. PubMed ID: 17036374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
    Kroschinsky FP; Schäkel U; Fischer R; Mohr B; Oelschlaegel U; Repp R; Schaich M; Soucek S; Baretton G; Ehninger G; Thiede C;
    Haematologica; 2008 Feb; 93(2):283-6. PubMed ID: 18223289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
    Sritana N; Auewarakul CU
    Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia.
    Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L
    Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing apples and oranges in normal karyotype acute myeloid leukemia.
    Medeiros BC
    J Clin Oncol; 2009 Jan; 27(3):474; author reply 474-6. PubMed ID: 19075259
    [No Abstract]   [Full Text] [Related]  

  • 11. [Age-specific characteristics of acute myeloid leukemia karyotype].
    Gritsaev SV; Martynkevich IS; Martynenko LS; Ivanova MP; Aksenova VIu; Moskalenko MV; Zapreeva IM; Abdulkadyrov KM
    Ter Arkh; 2011; 83(1):51-5. PubMed ID: 21446203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patients.
    Breccia M; Frustaci AM; Cannella L; Stefanizzi C; Latagliata R; Cartoni C; Diverio D; Guarini A; Nanni M; Rago A; Cimino G; Alimena G
    Hematol Oncol; 2009 Sep; 27(3):148-53. PubMed ID: 19274612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype.
    Jakobsen Falk I; Fyrberg A; Paul E; Nahi H; Hermanson M; Rosenquist R; Höglund M; Palmqvist L; Stockelberg D; Wei Y; Gréen H; Lotfi K
    Br J Haematol; 2014 Dec; 167(5):671-80. PubMed ID: 25155901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
    Büchner T; Berdel WE; Haferlach C; Haferlach T; Schnittger S; Müller-Tidow C; Braess J; Spiekermann K; Kienast J; Staib P; Grüneisen A; Kern W; Reichle A; Maschmeyer G; Aul C; Lengfelder E; Sauerland MC; Heinecke A; Wörmann B; Hiddemann W
    J Clin Oncol; 2009 Jan; 27(1):61-9. PubMed ID: 19047294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of acute myeloid leukemia.
    Döhner K; Döhner H
    Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
    [No Abstract]   [Full Text] [Related]  

  • 16. A rapid, one step assay for simultaneous detection of FLT3/ITD and NPM1 mutations in AML with normal cytogenetics.
    Huang Q; Chen W; Gaal KK; Slovak ML; Stein A; Weiss LM
    Br J Haematol; 2008 Jul; 142(3):489-92. PubMed ID: 18477048
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinically useful prognostic factors in acute myeloid leukemia.
    Ferrara F; Palmieri S; Leoni F
    Crit Rev Oncol Hematol; 2008 Jun; 66(3):181-93. PubMed ID: 17996460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
    Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
    Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical progress in acute myeloid leukemia. Preface.
    Rowe JM
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):597-9. PubMed ID: 19041598
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia.
    Tiribelli M; Geromin A; Damiani D
    Am J Hematol; 2017 Apr; 92(4):E45-E47. PubMed ID: 28076884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.